A Synthetic Tul4 and FopA Peptide Cocktail of Francisella tularensis Induces Humoral and Cell-Mediated Immune Responses in Mice
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Francisella tularensis is a highly virulent pathogen of humans and other mammals. Moreover, F. tularensis has been designated a category A biothreat agent, and there is growing interest in the development of a protective vaccine. In the present study, we determine the in vitro and in vivo immune responses of a subunit vaccine composed of recombinant peptides Tul4 and FopA from epitopes of the F. tularensis outer membrane proteins. The recombinant peptides with adjuvant CpG induced robust immunophenotypic change of dendritic cell (DC) maturation and secretion of inflammatory cytokines (IL-6, IL-12). In addition, the matured DCs enabled ex vivo proliferation of naive splenocytes in a mixed lymphocyte reaction. Lastly, we determined the in vivo immune response by assessment of antibody production in C57BL/ 6 mice. Total IgG levels were produced after immunization and peaked in 6 weeks, and moreover, Tul4-specific IgG was confirmed in the mice receiving peptides with or without CpG. Based on these results, we concluded that the recombinant peptides Tul4 and FopA have immunogenicity and could be a safe subunit vaccine candidate approach against F. tularensis.
Abstract
Francisella tularensis is a highly virulent pathogen of humans and other mammals. Moreover, F. tularensis has been designated a category A biothreat agent, and there is growing interest in the development of a protective vaccine. In the present study, we determine the in vitro and in vivo immune responses of a subunit vaccine composed of recombinant peptides Tul4 and FopA from epitopes of the F. tularensis outer membrane proteins. The recombinant peptides with adjuvant CpG induced robust immunophenotypic change of dendritic cell (DC) maturation and secretion of inflammatory cytokines (IL-6, IL-12). In addition, the matured DCs enabled ex vivo proliferation of naive splenocytes in a mixed lymphocyte reaction. Lastly, we determined the in vivo immune response by assessment of antibody production in C57BL/ 6 mice. Total IgG levels were produced after immunization and peaked in 6 weeks, and moreover, Tul4-specific IgG was confirmed in the mice receiving peptides with or without CpG. Based on these results, we concluded that the recombinant peptides Tul4 and FopA have immunogenicity and could be a safe subunit vaccine candidate approach against F. tularensis.
참고문헌 (22)
- Ashtekar AR, "A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS", PLoS One, 7, pp.e50460~ (2012)
- Conlan JW, "Tularemia vaccines: recent developments and remaining hurdles", Future Microbiol, 6, pp.391~405 (2011)
- Cristillo AD, "Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime", protein boost HIV-1 vaccine, 2006, pp.346, 151~168
- Dennis DT, "Tularemia as a biological weapon:medical and public health management", JAMA, 285, pp.2763~2773 (2001)
- Diehl S, "The two faces of IL-6 on Th1", Th2differentiation, 2002, pp.39, 531~536
- Gregory SH, "Epitope-based vaccination against pneumonic tularemia", Vaccine, 27, pp.5299~5306 (2009)
- Hickey AJ, "Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia", Vaccine, 29, pp.6941~6947 (2011)
- Huntley JF, "Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis", Infect. Immun, 76, pp.3664~3671 (2008)
- Jakob T, "Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA", J. Immunol, 161, pp.3042~3049 (1998)
- Kirimanjeswara GS, "Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis", Immunol. Rev, 225, pp.244~255 (2008)
- Kweon MN, "Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice. J. Immunol. 160 : 1687-1693", J. Immunol, 160, pp.1687~1693 (1998)
- Li W, "Peptide vaccine: progress and challenges", Vaccines, 2, pp.515~ (2014)
- Macatonia SE, "Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells", J. Immunol, 154, pp.5071~5079 (1995)
- Morecki S, "CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versushost disease in a murine model of allogeneic cell therapy", Biol. Blood Marrow Transplant, 14, pp.973~984 (2008)
- Napolitani G, "Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells", Nat. Immunol, 6, pp.769~776 (2005)
- Park SJ, "IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation", J. Immunol, 173, pp.3844~3854 (2004)
- Roberts LM, "TLR2 s ig naling i s required f or t he i nnate, but not adaptive response to LVS clpB", Front. Immunol, 5, pp.426~ (2014)
- Thakran S, "Identification of Francisella tularensis lipoproteins that stimulate the Toll-like receptor (TLR) 2", TLR1 heterodimer, 2008, pp.283, 3751~3760
- Valentino MD, "Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS", Mol. Immunol, 46, pp.1830~1838 (2009)
- Wang BZ, "Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection", PLoS One, 5, pp.e13972~ (2010)
- Wingender G, "Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO", Eur. J. Immunol, 36, pp.12~20 (2006)
- Zhou W, "Tolllike receptor 9 interaction with CpG ODN - an in silico analysis approach", Theor. Biol. Med. Model, 10, pp.18~ (2013)